Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Cash Flow-to-Debt Ratio
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥70.28 Million could theoretically repay 0% of its total liabilities (CN¥1.55 Billion) in one year. See 000403 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. Also explore 000403 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Pacific Shuanglin Bio pharmacy Co Ltd. For market capitalisation and broader financial context, see Pacific Shuanglin Bio pharmacy Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -164.4% |
| 2024 | 0.24x | CN¥321.79 Million | CN¥1.33 Billion | ▼ -56.9% |
| 2023 | 0.56x | CN¥679.01 Million | CN¥1.21 Billion | ▲ +20.2% |
| 2022 | 0.47x | CN¥524.22 Million | CN¥1.12 Billion | ▼ -12.9% |
| 2021 | 0.54x | CN¥408.22 Million | CN¥760.07 Million | ▲ +89.0% |
| 2020 | 0.28x | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.0% |
| 2019 | 0.41x | CN¥190.84 Million | CN¥470.04 Million | ▲ +143.0% |
| 2018 | 0.17x | CN¥116.63 Million | CN¥698.08 Million | ▲ +454.4% |
| 2017 | -0.05x | CN¥-35.91 Million | CN¥761.70 Million | ▼ -152.5% |
| 2016 | 0.09x | CN¥62.49 Million | CN¥696.41 Million | ▼ -5.6% |
| 2015 | 0.10x | CN¥70.31 Million | CN¥739.82 Million | ▼ -9.3% |
| 2014 | 0.10x | CN¥77.04 Million | CN¥735.16 Million | ▼ -3.8% |
| 2013 | 0.11x | CN¥91.01 Million | CN¥835.47 Million | ▼ -31.0% |
| 2012 | 0.16x | CN¥123.24 Million | CN¥780.27 Million | ▼ -17.7% |
| 2011 | 0.19x | CN¥130.14 Million | CN¥678.06 Million | ▲ +1165.7% |
| 2010 | 0.02x | CN¥9.88 Million | CN¥651.42 Million | ▼ -84.9% |
| 2009 | 0.10x | CN¥111.86 Million | CN¥1.11 Billion | ▲ +39.1% |
| 2008 | 0.07x | CN¥74.90 Million | CN¥1.04 Billion | ▲ +25.3% |
| 2007 | 0.06x | CN¥95.03 Million | CN¥1.65 Billion | ▲ +1058.2% |
| 2006 | -0.01x | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -124.1% |
| 2005 | 0.02x | CN¥49.06 Million | CN¥1.97 Billion | ▲ +128.6% |
| 2004 | -0.09x | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -146.5% |
| 2003 | -0.04x | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -117.0% |
| 2002 | 0.21x | CN¥159.18 Million | CN¥765.52 Million | ▲ +29.1% |
| 2001 | 0.16x | CN¥111.28 Million | CN¥690.82 Million | ▲ +241.0% |
| 2000 | 0.05x | CN¥27.36 Million | CN¥579.29 Million | ▲ +198.0% |
| 1999 | -0.05x | CN¥-23.08 Million | CN¥478.92 Million | ▼ -424.9% |
| 1998 | -0.01x | CN¥-2.65 Million | CN¥288.28 Million | — |